Experts find epigenetic changes moderate reality distortion in schizophrenia patients

June 10, 2013

A study in Schizophrenia Bulletin is among the first to indicate epigenetic changes related to immune function in schizophrenia. DNA methylation, a process involving the addition of a methyl group to the DNA without changing its sequence, can alter gene expression.

Led by Dr. Jingyu Liu, the nine researchers analyzed and verified changes in DNA methylation patterns in people with and without schizophrenia and found significant changes in seven genes that moderate immune responses.

In the current study, the researchers found that the seven genes that were up or down regulated protect against the delusion and hallucination symptoms in . This finding suggests that methylation changes related to immune function may be one of the pathways to moderate symptoms in schizophrenia patients.

Explore further: Gene regulator in brain's executive hub tracked across lifespan

More information: The paper "Methylation Patterns in Whole Blood Correlate With Symptoms in Schizophrenia Patients" can be accessed here:

Related Stories

Deciphering the cellular reading system of DNA methylation

April 12, 2013

(Medical Xpress)—Scientists from the FMI identify how a family of proteins reads the methylation marks on the DNA so critical for cell development. These MBD proteins bind directly to methylation marks and inactivate the ...

Genetic risk for schizophrenia is connected to reduced IQ

May 16, 2013

The relationship between the heritable risk for schizophrenia and low intelligence (IQ) has not been clear. Schizophrenia is commonly associated with cognitive impairments that may cause functional disability. There are clues ...

Recommended for you

New class of RNA tumor suppressors identified

November 23, 2015

A pair of RNA molecules originally thought to be no more than cellular housekeepers are deleted in over a quarter of common human cancers, according to researchers at the Stanford University School of Medicine. Breast cancer ...

Batten disease may benefit from gene therapy

November 11, 2015

In a study of dogs, scientists showed that a new way to deliver replacement genes may be effective at slowing the development of childhood Batten disease, a rare and fatal neurological disorder. The key may be to inject viruses ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.